CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine plus sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results

Sinn, M.; Liersch, T.; Riess, H.; Gellert, K.; Stuebs, P.; Waldschmidt, D.; Lammert, F.; Maschmeyer, G.; Bechstein, W.; Bitzer, M.; Denzlinger, C.; Hofheinz, R.; Lindig, U.; Ghadimi, M.; Hinke, A.; Striefler, J. K.; Pelzer, U.; Bischoff, S.; Bahra, M.; Oettle, H.

dc.contributor.author	Bitzer, Michael
dc.date.accessioned	2021-07-13T06:38:51Z
dc.date.available	2021-07-13T06:38:51Z
dc.date.issued	2020
dc.identifier.issn	1879-0852
dc.identifier.uri	http://hdl.handle.net/10900/117076
dc.language.iso	en	de_DE
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2020.06.032	de_DE
dc.subject.ddc	610	de_DE
dc.title	CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine plus sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210304112512_01347
utue.publikation.seiten	172-181	de_DE
utue.personen.roh	Sinn, M.
utue.personen.roh	Liersch, T.
utue.personen.roh	Riess, H.
utue.personen.roh	Gellert, K.
utue.personen.roh	Stuebs, P.
utue.personen.roh	Waldschmidt, D.
utue.personen.roh	Lammert, F.
utue.personen.roh	Maschmeyer, G.
utue.personen.roh	Bechstein, W.
utue.personen.roh	Bitzer, M.
utue.personen.roh	Denzlinger, C.
utue.personen.roh	Hofheinz, R.
utue.personen.roh	Lindig, U.
utue.personen.roh	Ghadimi, M.
utue.personen.roh	Hinke, A.
utue.personen.roh	Striefler, J. K.
utue.personen.roh	Pelzer, U.
utue.personen.roh	Bischoff, S.
utue.personen.roh	Bahra, M.
utue.personen.roh	Oettle, H.
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Volume	138	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE